Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Dionisio Mariano

Clinical Cardiac Electrophysiology Appleton, WI Medical Doctor

NPI 1649220229 CMS profile 1235543

5045 W Grande Market Dr, Appleton, WI 54913

Open in the dashboard

General payments

$3,990

37 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Dionisio Mariano of Appleton, WI is reported in the CMS Open Payments database as having received $3,990 across 37 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 18th percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,066 23
2024 General $15 1
2023 General $29 1
2022 General $752 9
2021 General $32 2
2019 General $97 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Dionisio Mariano
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Dionisio Mariano were reported at $3,066. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Dionisio Mariano Clinical Cardiac Electrophysiology median Middle half National median
2019 $97 $2,361 $585–$8,260 $163
2020 $0 $993 $247–$4,351 $114
2021 $32 $1,185 $326–$4,739 $132
2022 $752 $2,073 $554–$6,789 $149
2023 $29 $2,568 $759–$8,159 $160
2024 $15 $2,557 $703–$7,403 $164
2025 $3,066 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $3,588 24 payments
  2. Biosense Webster, Inc. $126 2 payments
  3. Cleerly, Inc. $75 1 payment
  4. Alnylam Pharmaceuticals Inc. $50 2 payments
  5. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $34 2 payments
  6. AstraZeneca Pharmaceuticals LP $30 2 payments
  7. Boston Scientific Corporation $29 1 payment
  8. Novartis Pharmaceuticals Corporation $24 1 payment
  9. Janssen Pharmaceuticals, Inc $18 1 payment
  10. Pfizer Inc. $15 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $2,051 26 payments
  2. Travel and Lodging $1,939 11 payments
Products named General payments · program years 2019–2025
  1. Micra $786 10 payments
  2. Carto 3 System $97 1 payment
  3. Cleerly Ischemia $75 1 payment
  4. Cleerly Labs $75 1 payment
  5. ONPATTRO $50 2 payments
  6. LifeVest $34 2 payments
  7. WATCHMAN Access System $29 1 payment
  8. Carto 3 $29 1 payment
  9. LEQVIO $24 1 payment
  10. XARELTO $18 1 payment
  11. Other $45 3 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 15 drugs

Part D claims

1,616

Median for Clinical Cardiac Electrophysiology: 1,090

Drug cost

$553,815

Median for Clinical Cardiac Electrophysiology: $354,841

Branded share of claims

38%

Median for Clinical Cardiac Electrophysiology: 38.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 325 $388,067
Xarelto Rivaroxaban Brand 101 $119,663
Dofetilide Generic 98 $17,288
Flecainide Acetate Generic 195 $8,805
Metoprolol Succinate Generic 308 $7,025
Mexiletine Hcl Generic 17 $2,555
Diltiazem 24hr Er (Cd) Diltiazem Hcl Brand 69 $2,225
Amiodarone Hcl Generic 136 $1,979
Sotalol Sotalol Hcl Brand 73 $1,829
Metoprolol Tartrate Generic 159 $1,747

The 10 drugs with the highest cost, of 15 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,573 Part D prescribers listed as Clinical Cardiac Electrophysiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 64 billing codes

Paid by Medicare

$86,242

Medicare's payments for the services billed

Medicare patients

380

Average age 75

Services billed

1,736

161 women, 219 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Atrial fibrillation 69%
Heart failure 54%
Ischemic heart disease 48%
Arthritis 43%
Diabetes 33%
Chronic kidney disease 33%
Depression 21%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

37 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in Wisconsin

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record